Late breaking trials of 2014 in structural heart disease and peripheral arterial disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|86|1|80-84

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.86, Iss.1, 2015-07, pp. : 80-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Late breaking trials of 2014 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 1, 2015-07 ,pp. : 73-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelines

By Mohler Emile   Giri Jay  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2509-2522

Informa Healthcare

Access to resources Recommend Favorite

Women and peripheral arterial disease

By Vavra Ashley K   Kibbe Melina R  

Women's Health, Vol. 5, Iss. 6, 2009-11 ,pp. : 669-683

Future Medicine

Access to resources Recommend Favorite

Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65–74 years from a population screening study (VIVA trial)

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 8, 2015-07 ,pp. : 902-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peripheral arterial disease: a literature review

By Abdulhannan P.   Russell D. A.   Homer-Vanniasinkam S.  

British Medical Bulletin, Vol. 104, Iss. 1, 2012-12 ,pp. : 21-39

Oxford University Press

Access to resources Recommend Favorite